During the past decade, Kaiser Permanente Northwest Region Oncology Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Northwest Region Oncology Hematology" #1 sponsor was "Astellas Pharma Inc" with 1 trials, followed by "Gilead Sciences" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Puma Biotechnology, Inc." with 1 trials sponsored and "Threshold Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Northwest Region Oncology Hematology" #1 collaborator was "Agensys, Inc." with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Northwest Region Oncology Hematology" are "Breast Cancer" (1 trials), "Carcinoma, Pancreatic Ductal" (1 trials), "Colorectal Cancer" (1 trials), "Metastatic or Unresectable Cutaneous Melanoma" (1 trials) and "Pancreatic Adenocarcinoma" (1 trials). Many other conditions were trialed in "Kaiser Permanente Northwest Region Oncology Hematology" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Northwest Region Oncology Hematology" are "Drug" (4 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AGS-1C4D4" (1 trials), "Dacarbazine" (1 trials), "Fluorouracil" (1 trials), "Gemcitabine" (1 trials) and "Gemzar (Gemcitabine)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Northwest Region Oncology Hematology" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente Northwest Region Oncology Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kaiser Permanente Northwest Region Oncology Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Northwest Region Oncology Hematology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".